Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$57.86M-11.3%$65.26M+11.9%$58.3M+2.9%$56.64M-6.7%$60.73M+5.4%
$219.69M+1.8%$215.8M-10.9%$242.19M-6.8%$259.93M-8.7%$284.6M-14.9%
$29.35M-17.2%$35.45M+15.8%$30.62M-5.1%$32.26M+1.9%$31.65M+15.0%
$79.92M-1.8%$81.4M-2.4%$83.41M-4.8%$87.63M+5.8%$82.82M+1.6%
$369.52M-1.5%$375.05M-4.9%$394.24M-4.6%$413.4M-7.1%$444.92M-10.2%
$24.38M+1.0%$24.15M+9.1%$22.13M-4.2%$23.1M-6.8%$24.79M-18.7%
$317.76M0.0%$317.76M0.0%$317.76M0.0%$317.76M0.0%$317.76M0.0%
$14.1M-6.7%$15.12M-6.3%$16.14M-5.9%$17.16M-5.6%$18.18M-95.3%
$782.37M-0.2%$784.08M-2.4%$803.16M-2.7%$825.47M-4.1%$860.79M-31.7%
$13.61M-34.5%$20.77M+26.9%$16.36M+8.7%$15.06M+7.3%$14.04M-15.4%
$16.33M+2.5%$15.94M-0.7%$16.05M+8.0%$14.86M-2.5%$15.24M+9.9%
$65.36M-10.3%$72.83M+15.2%$63.21M+5.8%$59.75M-10.3%$66.6M+0.5%
$780M+0.2%$778.73M$0$0$0-100%
1B0.0%1B0.0%1B0.0%1B0.0%1B+340,036%
-$2.7B-0.3%-$2.7B-1.5%-$2.65B-1.5%-$2.62B-1.6%-$2.58B-19.8%
$2.37M-55.8%$5.35M-85.2%$36.09M-41.3%$61.49M-32.9%$91.64M-81.9%
$782.37M-0.2%$784.08M-2.4%$803.16M-2.7%$825.47M-4.1%$860.79M-31.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Pacific Biosciences of California's total assets?
Pacific Biosciences of California (PACB) holds $782.4M in total assets, down 9.1% year over year.
How much debt does Pacific Biosciences of California have?
Pacific Biosciences of California carries $59.3M in total debt against $2.4M of shareholders' equity, a debt-to-equity ratio of 25.06.
How much cash does Pacific Biosciences of California have?
Pacific Biosciences of California holds $57.9M in cash and equivalents.
Can Pacific Biosciences of California cover its short-term obligations?
Its current ratio is 5.65 — current assets exceed current liabilities.
Where does Pacific Biosciences of California's balance sheet data come from?
Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.